On Monday, Citigroup Inc (NYSE:C)’s shares declined -0.65% to $52.37.
Citi’s Issuer Services business, acting through Citibank, N.A., has been designated by Vale S.A., one of the largest metals and mining companies in the world, as the successor depositary bank for its sponsored American Depositary Receipt (ADR) programs.
Vale’s ADRs are traded on the New York Stock Exchange under the symbol “VALE” for its ADRs representing common shares and “VALE.P” for its ADRs representing preferred shares. Each ADR represents one common or one preferred share, respectively. Vale is based in Brazil and its underlying common and preferred shares are listed on the BM&FBOVESPA Stock Exchange.
“We look forward to working with Citi to further develop and improve our ADR program. Providing value for our ADR holders is an important commitment,” said Luciano Siani, CFO of Vale.
“We are honored to be designated successor depositary bank for Vale’s ADR programs,” said Dirk Jones, Head of Global Issuer Services at Citi. “With Citi’s unparalleled global presence and investor relations expertise, we are confident we can facilitate the continued success of Vale’s ADR programs and provide best-in-class service to its ADR holders.”
Citigroup Inc., a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions worldwide.
Gilead Sciences, Inc. (NASDAQ:GILD)’s shares dropped -1.83% to $101.68. With its recent share price change, GILD market value has reached roughly $149.28 billion. Its most recent quarter balance sheet showed the company is standing at a 2.80 current ratio and possess -1.28 as debt to equity ratio. The company has a Profit Margin (ttm) of positive 53.80% and has 87.30% gross margins. The operating profit margin is 66.50%. The stock’s performance in 1 month is -5.25% and its volatility for the same period is 1.20%.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific.
Tenet Healthcare Corp (NYSE:THC)‘s shares dipped -3.81% to $31.04. The last trading range of Tenet Healthcare Corp (NYSE:THC) ranges between $30.48 and $32.24. The EPS of the company stands at $0.14. The 52-week range shows that the stock reached higher at $60.93 while its lower range is $26.60 in the last 52-weeks. The average volume of the company is at 2.50 million with the Outstanding Shares of 99.67 million. The market capitalization of the company is $3.22 billion. The Beta of the company stands at 1.76 with the RSI (Relative Strength Index) of 50.41.
Tenet Healthcare Corporation, a healthcare services company, primarily operates acute care hospitals and related healthcare facilities in the United States. It operates through two segments, Hospital Operations and Other, and Conifer. The company’s general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
